Cosmetic Bioanalysis Using LC–MS: Challenges and Future Outlook

Abstract

BioanalysisVol. 6, No. 4 CommentaryCosmetic bioanalysis using LC–MS: challenges and future outlookWanlong Zhou & Perry G WangWanlong ZhouUS FDA, Center for Food Safety & Applied Nutrition, Office of Regulatory Science, 5100 Paint Branch Parkway, College Park, MD 20740, USASearch for more papers by this author & Perry G Wang* Author for correspondenceUS FDA, Center for Food Safety & Applied Nutrition, Office of Regulatory Science, 5100 Paint Branch Parkway, College Park, MD 20740, USA. Search for more papers by this authorEmail the corresponding author at perry.wang@fda.hhs.govPublished Online:25 Feb 2014https://doi.org/10.4155/bio.13.246AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInReddit View articleKeywords: carryovercosmeticsLC–MSmatrix effectsweighting factorReferences1 Zhang XL, Wang NN, Zhou, YF et al. Extractive electrospray ionization mass spectrometry for direct characterization of cosmetic products. Anal. Methods5(2),311–315 (2013).Crossref, CAS, Google Scholar2 Zhou W, Wang PG, Ogunsola OA et al. Rapid determination of hexapeptides by hydrophilic interaction LC–MS/MS for in vitro skin-penetration studies. Bioanalysis5(11),1353–1362 (2013).Link, CAS, Google Scholar3 Malik AK, Blasco C, Picó Y. Liquid chromatography–mass spectrometry in food safety. J. Chromatogr. A1217(25),4018–4040 (2010).Crossref, Medline, CAS, Google Scholar4 Zedda M, Zwiener C. Is nontarget screening of emerging contaminants by LC–HRMS successful? A plea for compound libraries and computer tools. Anal. Bioanal. Chem.403(9),2493–2502 (2012).Crossref, Medline, CAS, Google Scholar5 Dolan JW. Autosampler carryover. LC GC N. Am.24(8),754–760 (2006).CAS, Google Scholar6 Zhou W, Wang PW, Krynitsky AJ, Rader JI. Rapid and simultaneous determination of hexapeptides (Ac-EEMQRR-amide and H2N-EEMQRR-amide) in anti-wrinkle cosmetics by hydrophilic interaction liquid chromatography–solid phase extraction preparation and hydrophilic interaction liquid chromatography with tandem mass spectrometry. J. Chromatogr. A1218(44),7956–7963 (2011).Crossref, Medline, CAS, Google Scholar7 Gäbet V, Miège C, Bados P et al. Analysis of estrogens in environmental matrices. TRAC-Trend. Anal. Chem.26(11),1113–1131 (2007).CAS, Google Scholar8 Kiser MM, Dolan JW. Selecting the best curve fit. LC GC N. Am.22(2),112–117 (2004).CAS, Google Scholar101 EU COMMISSION. Implementing Council Directive 96/23/EC concerning the performance of analytical methods and the interpretation of results. http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2002:221:0008:0036:EN:PDFGoogle Scholar102 US FDA Office of Regulatory Affairs. ORA-WIDE PROCEDURE. Guidance for the analysis and documentation to support regulatory action on pesticide residues. http://inside.fda.gov:9003/downloads/ORA/OfficeofRegionalOperations/DivisionofFieldScience/UCM189632.pdfGoogle Scholar103 National Center for Biotechnology Information. www.ncbi.nlm.nih.govGoogle Scholar104 ChemSpider. www.chemspider.comGoogle Scholar105 US FDA Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM), Guidance for Industry Bioanalytical Method Validation. www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm368107.pdfGoogle ScholarFiguresReferencesRelatedDetailsCited ByArgireline: Needle‐Free Botox as Analytical Challenge8 February 2021 | Chemistry & Biodiversity, Vol. 18, No. 3 Vol. 6, No. 4 Follow us on social media for the latest updates Metrics Downloaded 160 times History Published online 25 February 2014 Published in print February 2014 Information© Future Science LtdKeywordscarryovercosmeticsLC–MSmatrix effectsweighting factorAcknowledgementsThe authors wish to thank JI Rader, AJ Krynitsky, WG Wamer, SR Milstein, PA Hansen and LM Katz (US FDA, Center for Food Safety and Applied Nutrition) for helpful discussions.Financial & competing interests disclosureThe authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.No writing assistance was utilized in the production of this manuscript.PDF download